Publication Date


Document Type



Science Department

Faculty Mentor

Dr. Mary Ann Yang


Fibrolamellar Hepatocellular Carcinoma (FL-HCC), a rare primary liver cancer, differs from the most common liver cancer, hepatocellular carcinoma, as FL-HCC is not correlated with chronic liver diseases. Mayo Clinic conducted a proteomic screening and found the proline biosynthetic pathway to be dysregulated in FL-HCC patients. In liver cells, free proline has been shown to induce the mTOR pathway, which stimulates cell proliferation through upregulation of full-length Cyclin E (FL-E). In addition, FL-E can be partially cleaved by an enzyme called serine protease neutrophil elastase, creating low molecular weight cyclin E (LMW-E) that has been linked to tumorigenesis. To further investigate the expression of FL-E and LMW-E; we performed western blot and densitometry analysis in FL-HCC and normal liver samples. Preliminary results found significant differences between the expression of Cyclin E. LMW-E was seen in a higher expression level than the FL-E when comparing FL-HCC samples to the normal liver samples. More experiments are currently underway to further investigate this disparity.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.